{"id":2271,"date":"2026-11-13T16:24:46","date_gmt":"2026-11-13T16:24:46","guid":{"rendered":"https:\/\/nulifespanrx.com\/blog\/?p=2271"},"modified":"2026-11-13T16:24:46","modified_gmt":"2026-11-13T16:24:46","slug":"metformin-for-longevity-tame-trial","status":"publish","type":"post","link":"https:\/\/nulifespanrx.com\/blog\/metformin-for-longevity-tame-trial\/","title":{"rendered":"Metformin for Longevity: What the Research and the TAME Trial Actually Show"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Metformin for longevity is a popular idea, but it is not a proven one. Metformin is a decades-old, low-cost type 2 diabetes drug that affects several biological pathways linked to aging, and some studies of people with diabetes suggest metformin users live longer than expected. However, no completed randomized trial has shown that metformin slows aging or extends lifespan in people without diabetes. Its potential anti-aging benefits remain under investigation.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Metformin is already a familiar option in<\/span><a href=\"https:\/\/nulifespanrx.com\/blog\/type-2-diabetes-medication-comparison\/\"> <span style=\"font-weight: 400;\">type 2 diabetes treatment<\/span><\/a><span style=\"font-weight: 400;\">, which is a separate question from whether it can slow aging in healthy people. The trial designed to answer that second question, Targeting Aging with Metformin, is described on the<\/span><a href=\"https:\/\/www.afar.org\/research\/TAME\/\"> <span style=\"font-weight: 400;\">American Federation for Aging Research&#8217;s official TAME page<\/span><\/a><span style=\"font-weight: 400;\"> as still needing funding to launch. This article separates what is established, what is being studied, and what remains unproven.<\/span><\/p>\n<h2>Pay Less for Medicines Your Doctor Prescribes<\/h2>\n<p><span style=\"font-weight: 400;\">Generic medicines like metformin are often inexpensive, but the counter price still differs from one pharmacy to the next, and other prescriptions can cost far more. The NuLifeSpan Rx discount card, which costs nothing to get, shows the discounts available at participating pharmacies. It is a savings program, not insurance, and it is meant for medicines a licensed prescriber has ordered for you.<\/span><\/p>\n<p><a href=\"https:\/\/nulifespanrx.com\/\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter wp-image-2272 size-full\" src=\"https:\/\/nulifespanrx.com\/blog\/wp-content\/uploads\/2026\/11\/nulifespan-rx-free-prescription-discount-card-cta.webp\" alt=\"nulifespan-rx-free-prescription-discount\" width=\"800\" height=\"500\" srcset=\"https:\/\/nulifespanrx.com\/blog\/wp-content\/uploads\/2026\/11\/nulifespan-rx-free-prescription-discount-card-cta.webp 800w, https:\/\/nulifespanrx.com\/blog\/wp-content\/uploads\/2026\/11\/nulifespan-rx-free-prescription-discount-card-cta-300x188.webp 300w, https:\/\/nulifespanrx.com\/blog\/wp-content\/uploads\/2026\/11\/nulifespan-rx-free-prescription-discount-card-cta-768x480.webp 768w, https:\/\/nulifespanrx.com\/blog\/wp-content\/uploads\/2026\/11\/nulifespan-rx-free-prescription-discount-card-cta-400x250.webp 400w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/><\/a><\/p>\n<h2><span style=\"font-weight: 400;\">What Is Metformin and What Is It Approved to Treat?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Metformin is a biguanide, a class of oral diabetes medicine first approved in the United States in 1995. The FDA has approved it to improve blood sugar control in adults and certain children with type 2 diabetes, used along with diet and exercise. It lowers blood glucose mainly by reducing the amount of sugar the liver releases and by helping muscles respond better to insulin. On its own, it rarely causes low blood sugar.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Doctors also prescribe metformin off-label, meaning for uses not listed on the FDA label. Examples include prediabetes in some higher-risk adults, polycystic ovary syndrome, and weight gain linked to certain psychiatric medicines. Off-label prescribing is legal and common, but it is a clinical judgment for an individual patient. Metformin is not FDA-approved to treat aging, slow aging, or extend lifespan, and the FDA does not currently recognize aging itself as a condition a drug can be approved to treat.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">Why Scientists Are Studying Metformin for Longevity<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Interest in metformin anti-aging research grew from two directions: laboratory evidence that it touches pathways tied to aging, and observational data from people with diabetes. The mechanisms below are hypotheses about how metformin might influence aging biology. They are real effects seen in cells, animals, or tissue samples, but none of them proves that metformin helps humans live longer.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">AMPK Signaling<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">AMPK is an enzyme that acts like a cellular fuel gauge. When energy runs low, AMPK switches on processes that conserve energy and improve fuel use. Metformin activates AMPK, and similar signaling is seen with calorie restriction, which extends lifespan in many animal species.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Mitochondrial Function<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Mitochondria are the power plants of cells. Metformin mildly inhibits a part of the mitochondrial energy chain called complex I. That small energy stress appears to trigger AMPK activation and other protective responses, although the same effect may also explain why metformin can blunt some benefits of exercise.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">mTOR-Related Pathways<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">mTOR is a growth-signaling hub that, when overactive, is linked with aging in lab research. Rapamycin, the drug with the strongest animal evidence for longevity, works by inhibiting mTOR. Metformin dampens mTOR signaling indirectly, which is one reason researchers group them together.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Metabolic Regulation<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Metformin improves insulin sensitivity and lowers blood glucose and insulin levels. Because high insulin and glucose are associated with many age-related diseases, improving metabolic health is a plausible route to better healthspan, at least in people with metabolic problems.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Inflammation and Cellular Aging<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Lab and small human studies suggest metformin may lower some markers of chronic inflammation and influence cellular senescence, the state in which damaged cells stop dividing and release inflammatory signals. These findings are early and inconsistent, and changes in a biomarker do not guarantee changes in health outcomes.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">What Does Research Actually Show About Metformin and Aging?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">The evidence falls into four tiers, and they carry very different weight. Randomized controlled trials, in which people are assigned to drug or placebo by chance, are the strongest test of cause and effect. Observational studies can reveal associations but are vulnerable to bias. Animal studies generate hypotheses but often fail to carry over to people.<\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-2275 aligncenter\" src=\"https:\/\/nulifespanrx.com\/blog\/wp-content\/uploads\/2026\/11\/metformin-aging-research-nulifespan-rx.webp.webp\" alt=\"Metformin Longevity Research Studies\" width=\"800\" height=\"500\" srcset=\"https:\/\/nulifespanrx.com\/blog\/wp-content\/uploads\/2026\/11\/metformin-aging-research-nulifespan-rx.webp.webp 800w, https:\/\/nulifespanrx.com\/blog\/wp-content\/uploads\/2026\/11\/metformin-aging-research-nulifespan-rx.webp-300x188.webp 300w, https:\/\/nulifespanrx.com\/blog\/wp-content\/uploads\/2026\/11\/metformin-aging-research-nulifespan-rx.webp-768x480.webp 768w, https:\/\/nulifespanrx.com\/blog\/wp-content\/uploads\/2026\/11\/metformin-aging-research-nulifespan-rx.webp-400x250.webp 400w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/><\/p>\n<h3><span style=\"font-weight: 400;\">Animal Experiments<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Metformin has extended lifespan in some worm studies and in certain mouse experiments, including a 2013 study in male mice given a low dose. Results have been mixed. In the National Institute on Aging&#8217;s Interventions Testing Program, which tests compounds in genetically diverse mice at three sites, metformin alone at the tested dose did not significantly extend lifespan. Metformin combined with rapamycin did extend lifespan in that program, although the comparison relied partly on earlier rapamycin-only studies.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Observational Studies in Humans<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">A 2014 UK study by Bannister and colleagues is the most cited. It found that people with type 2 diabetes who started on metformin alone had slightly longer survival than matched people without diabetes, while those who started on a sulfonylurea did worse. Many other observational studies link metformin use with lower rates of cancer, heart disease, or dementia in people with diabetes.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">These findings have important limits. People prescribed metformin may differ from others in ways that also affect survival, a problem called confounding. In the Bannister study, people who needed additional diabetes drugs left the metformin-only group, which may have removed sicker patients from the comparison. A later Danish analysis that applied a similar approach did not find the same survival advantage. Most importantly, all of these participants had diabetes, so the results describe metformin compared with other diabetes care, not metformin as a longevity drug for healthy people. Association is not causation.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Randomized Controlled Trials<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Randomized trials in diabetes, such as the UK Prospective Diabetes Study, showed that metformin improved outcomes in overweight adults with type 2 diabetes. In the Diabetes Prevention Program, metformin lowered the risk of developing diabetes in adults with prediabetes, though intensive lifestyle change worked better.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Trials in older adults without diabetes have been small and focused on biomarkers or physical function, not lifespan. The MILES study found metformin changed gene activity in muscle and fat tissue in older adults with impaired glucose tolerance. Two exercise trials, covered in their own section below, looked at whether metformin changes training results. The<\/span><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40147475\/\"> <span style=\"font-weight: 400;\">MET-PREVENT trial<\/span><\/a><span style=\"font-weight: 400;\">, published in 2025, tested four months of metformin in 72 adults around age 80 with probable sarcopenia and prefrailty or frailty, and it did not improve their walking speed.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Remaining Research Gaps<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">The missing piece is a large, long trial in people without diabetes that measures the onset of age-related diseases, rather than lab markers or short-term fitness. That is exactly the gap TAME was designed to fill.<\/span><\/p>\n<table>\n<tbody>\n<tr>\n<td><b>Study or research category<\/b><\/td>\n<td><b>Population<\/b><\/td>\n<td><b>Main findings<\/b><\/td>\n<td><b>Limitations<\/b><\/td>\n<td><b>What can reasonably be concluded<\/b><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Worm and mouse studies<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Laboratory animals<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Lifespan extension in some studies; no significant extension with metformin alone in the NIA Interventions Testing Program<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Inconsistent results; animals differ from humans<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Biologically plausible, not proof of human benefit<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Bannister 2014 and similar cohort studies<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Adults with type 2 diabetes vs. matched controls<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Survival on par with, or a little above, matched controls<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Confounding, selection bias, not replicated in all datasets<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Metformin appears favorable within diabetes care; says little about healthy adults<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Diabetes Prevention Program<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Adults with prediabetes<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Metformin reduced progression to diabetes<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Not designed to measure aging or lifespan<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Useful for diabetes prevention in selected people<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">MASTERS and aerobic training trials<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Healthy older adults exercising<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Metformin reduced gains in muscle mass or fitness<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Short duration, modest size<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Possible trade-off with exercise benefits<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">MET-PREVENT (2025)<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Adults about 80 with sarcopenia and prefrailty or frailty<\/span><\/td>\n<td><span style=\"font-weight: 400;\">No improvement in walking speed; more side effects<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Small, four months<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Unlikely to help physical function in this group<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">TAME<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Planned: older adults without diabetes<\/span><\/td>\n<td><span style=\"font-weight: 400;\">None yet<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Not yet conducted<\/span><\/td>\n<td><span style=\"font-weight: 400;\">The key question remains unanswered<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span style=\"font-weight: 400;\">What Is the TAME Trial?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">TAME stands for Targeting Aging with Metformin. It was proposed by a group of aging researchers, led by Dr. Nir Barzilai of Albert Einstein College of Medicine, in a 2016 paper in Cell Metabolism. The trial is as much about proving a concept as about metformin itself: that one drug can target the biology of aging and delay several age-related diseases at once.<\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-2276 aligncenter\" src=\"https:\/\/nulifespanrx.com\/blog\/wp-content\/uploads\/2026\/11\/tame-trial-metformin-longevity-research.webp\" alt=\"Metformin TAME Trial Research\" width=\"800\" height=\"500\" srcset=\"https:\/\/nulifespanrx.com\/blog\/wp-content\/uploads\/2026\/11\/tame-trial-metformin-longevity-research.webp 800w, https:\/\/nulifespanrx.com\/blog\/wp-content\/uploads\/2026\/11\/tame-trial-metformin-longevity-research-300x188.webp 300w, https:\/\/nulifespanrx.com\/blog\/wp-content\/uploads\/2026\/11\/tame-trial-metformin-longevity-research-768x480.webp 768w, https:\/\/nulifespanrx.com\/blog\/wp-content\/uploads\/2026\/11\/tame-trial-metformin-longevity-research-400x250.webp 400w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/><\/p>\n<h3><span style=\"font-weight: 400;\">Research Objectives and Why the Trial Matters<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">The investigators want to show that delaying a cluster of age-related diseases is a valid goal for a drug trial. If that works, it could open a regulatory path for testing other drugs against aging itself, instead of one disease at a time. The team also hopes to bank blood samples that could help identify reliable biomarkers of aging. Metformin was picked because it is cheap, widely available, and has a long safety record in diabetes care, which lowers the risk of testing it in older volunteers.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Original Proposed Trial Design<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">As described by AFAR and the investigators, TAME is planned as a six-year, randomized, double-blind, placebo-controlled study at 14 US research institutions. Published descriptions call for 1,500 mg of metformin daily compared with a matching placebo. The design was developed with FDA input on using a composite of age-related diseases as the main outcome.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Proposed Participant Population<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">The plan calls for more than 3,000 adults aged 65 to 79 who do not have diabetes. Leaving out people with diabetes is deliberate, because it tests metformin as a possible aging intervention rather than as diabetes treatment.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Planned Outcome Measures<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">The primary outcome is the time until a participant develops one of several major age-related events, including cardiovascular disease, cancer, dementia, or death. Physical function and other markers of aging are expected as secondary measures.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Organizations Involved<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">AFAR manages the TAME initiative and leads its fundraising. Wake Forest University School of Medicine is named as the coordinating center, and the NIH-funded Geroscience Network recommended metformin as the drug to test.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Latest Verified Trial Status<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">As of November 2026, AFAR&#8217;s official TAME page still describes the trial in future terms and says it is raising funds to launch the multi-year, multi-site study. The page does not report recruitment underway, and no efficacy results have been published. Because metformin is generic, no company stands to profit from paying for a large trial, and reports have put the projected cost in the tens of millions of dollars. Some websites claim TAME has finished enrollment or reported findings. We could not confirm those claims through official trial sources, so treat them with caution.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">Has the TAME Trial Proven That Metformin Slows Aging?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">No. A trial that has not run cannot prove anything, so any claim that TAME showed metformin extends life or delays disease is inaccurate. It also helps to know what a positive result would and would not mean. Success would show that metformin delays a group of age-related diseases in older adults without diabetes. It would not, by itself, show that metformin is right for younger people, or reveal the best dose or starting age.<\/span><\/p>\n<h2>Look Up Today&#8217;s Price Before Your Next Fill<\/h2>\n<p><span style=\"font-weight: 400;\">Whether your prescription is a long-standing generic or something new, a quick price check can reveal a cheaper pharmacy nearby. Search your medicine and strength to see current prices from multiple pharmacies in one place.<\/span><\/p>\n<p><a href=\"https:\/\/nulifespanrx.com\/pricing\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-2273 aligncenter\" src=\"https:\/\/nulifespanrx.com\/blog\/wp-content\/uploads\/2026\/11\/Compare-Pricing.webp\" alt=\"nulifespan rx check prices\" width=\"800\" height=\"500\" srcset=\"https:\/\/nulifespanrx.com\/blog\/wp-content\/uploads\/2026\/11\/Compare-Pricing.webp 800w, https:\/\/nulifespanrx.com\/blog\/wp-content\/uploads\/2026\/11\/Compare-Pricing-300x188.webp 300w, https:\/\/nulifespanrx.com\/blog\/wp-content\/uploads\/2026\/11\/Compare-Pricing-768x480.webp 768w, https:\/\/nulifespanrx.com\/blog\/wp-content\/uploads\/2026\/11\/Compare-Pricing-400x250.webp 400w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/><\/a><\/p>\n<h2><span style=\"font-weight: 400;\">Can Metformin Extend Human Lifespan or Healthspan?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Lifespan is how long a person lives. Healthspan is how many of those years are spent in good health, free of serious chronic disease and disability. Many aging researchers care more about healthspan, and TAME&#8217;s disease-based outcome reflects that focus.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Current evidence does not show that metformin extends human lifespan. For healthspan, the picture is mixed. In people with type 2 diabetes, metformin is a well-established treatment and observational studies link it with fewer complications. In people without diabetes, small trials have not shown clear gains in function, and some show potential downsides when combined with exercise. Metformin and lifespan in humans remains an unanswered research question.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">Is Metformin Beneficial for Healthy Adults Without Diabetes?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Evidence specifically involving people without diabetes is limited and largely short term. The clearest benefit is diabetes prevention in certain adults with prediabetes, a use that is supported by randomized evidence and some professional guidelines. For costs related to that use, see our guide to<\/span><a href=\"https:\/\/nulifespanrx.com\/blog\/prediabetes-medication-prevention-program-costs\/\"> <span style=\"font-weight: 400;\">prediabetes medication and prevention programs<\/span><\/a><span style=\"font-weight: 400;\">.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Results from diabetes populations cannot automatically be applied to healthy adults. People with diabetes start with high blood sugar and insulin resistance, so a drug that corrects those problems may help them in ways that do not apply to someone with normal metabolism. In metabolically healthy people, small trials suggest metformin may offer little benefit and could reduce some gains from exercise. Researchers sometimes describe this as metformin helping most when there is a metabolic problem to fix.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">Metformin Risks, Side Effects, and Long-Term Safety<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Metformin is considered safe and well tolerated for most people with type 2 diabetes when it is used as prescribed and monitored. Like any prescription medicine, it carries risks that matter even more when the goal is speculative. The points below reflect FDA prescribing information and FDA safety communications.<\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-2281 aligncenter\" src=\"https:\/\/nulifespanrx.com\/blog\/wp-content\/uploads\/2026\/11\/metformin-risks-side-effects-safety.webp\" alt=\"Doctor Discussing Metformin Safety\" width=\"800\" height=\"500\" srcset=\"https:\/\/nulifespanrx.com\/blog\/wp-content\/uploads\/2026\/11\/metformin-risks-side-effects-safety.webp 800w, https:\/\/nulifespanrx.com\/blog\/wp-content\/uploads\/2026\/11\/metformin-risks-side-effects-safety-300x188.webp 300w, https:\/\/nulifespanrx.com\/blog\/wp-content\/uploads\/2026\/11\/metformin-risks-side-effects-safety-768x480.webp 768w, https:\/\/nulifespanrx.com\/blog\/wp-content\/uploads\/2026\/11\/metformin-risks-side-effects-safety-400x250.webp 400w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/><\/p>\n<h3><span style=\"font-weight: 400;\">Gastrointestinal Side Effects<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Diarrhea, nausea, stomach upset, gas, and a metallic taste are the most common side effects, especially when starting. Taking it with meals, increasing the dose slowly, or using an extended-release form often helps. Tolerance can be worse in frail older adults: in MET-PREVENT, 40 percent of participants stopped metformin, compared with 14 percent on placebo.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Vitamin B12 Deficiency<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Long-term use can lower vitamin B12 levels, which may contribute to anemia or nerve symptoms such as numbness and tingling. Prescribing information recommends periodic B12 checks. Our article on<\/span><a href=\"https:\/\/nulifespanrx.com\/blog\/b12-deficiency-prescription-treatment-costs\/\"> <span style=\"font-weight: 400;\">B12 deficiency treatment options<\/span><\/a><span style=\"font-weight: 400;\"> covers how low levels are treated.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Kidney Function Considerations<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Metformin is cleared by the kidneys. According to the<\/span><a href=\"https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-revises-warnings-regarding-use-diabetes-medicine-metformin-certain\"> <span style=\"font-weight: 400;\">FDA drug safety communication on metformin and kidney function<\/span><\/a><span style=\"font-weight: 400;\">, kidney function should be checked before starting and at least yearly, more often in older adults. Metformin is contraindicated when eGFR is below 30, starting it is not recommended when eGFR is between 30 and 45, and it may need to be paused around certain imaging procedures that use iodinated contrast dye.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Rare but Serious Lactic Acidosis<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Metformin carries a boxed warning for lactic acidosis, a rare but potentially fatal buildup of acid in the blood. Risk rises with kidney impairment, age 65 or older, severe infection, dehydration, surgery, heart failure with low oxygen levels, liver disease, and heavy alcohol use. Symptoms include unusual muscle pain, trouble breathing, unusual sleepiness, and stomach pain. These require immediate medical care.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Potential Drug Interactions<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Some medicines can raise metformin levels, including certain drugs that compete for kidney transport, such as ranolazine, dolutegravir, and cimetidine. Carbonic anhydrase inhibitors such as topiramate may add to lactic acidosis risk. Combining metformin with insulin or sulfonylureas increases the chance of low blood sugar.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Situations Requiring Additional Caution<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Extra caution applies to people with reduced kidney function, liver disease, heart failure, a history of heavy drinking, upcoming surgery or contrast imaging, and frail older adults. Anyone taking metformin should tell every clinician and pharmacist they see.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">Metformin and Exercise: Could There Be Trade-Offs?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Exercise is one of the best-proven ways to protect healthspan, so how metformin interacts with it matters. In the<\/span><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31557380\/\"> <span style=\"font-weight: 400;\">MASTERS trial<\/span><\/a><span style=\"font-weight: 400;\">, healthy adults aged 65 and older did 14 weeks of resistance training while taking 1,700 mg of metformin daily or a placebo. The placebo group gained more lean body mass and thigh muscle than the metformin group.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">A separate 2019 trial of 12 weeks of aerobic training in older adults found that metformin reduced the usual improvements in insulin sensitivity and maximal aerobic fitness, and it blocked the expected increase in muscle mitochondrial function. Responses varied, and some people still improved. These were short, modest-sized studies in healthy volunteers, so they do not prove harm over the long term. They do suggest that adding metformin to an exercise routine may not offer the combined benefit many people assume.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">Should You Take Metformin for Longevity?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">For people without diabetes, current evidence does not support starting metformin solely to slow aging or live longer. The potential benefits are unproven in this group, while side effects, B12 depletion, kidney monitoring, and a possible blunting of exercise gains are real considerations. Many researchers who are optimistic about metformin still advise against taking it for longevity outside a clinical trial.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Your situation may be different if you have prediabetes, type 2 diabetes, or another condition where metformin has an established role. A qualified healthcare professional can weigh your blood sugar, kidney function, other medicines, and goals. In the meantime, the habits with the strongest evidence for healthspan remain regular physical activity, a nutritious diet, not smoking, good sleep, and managing blood pressure and cholesterol.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">What Researchers Still Need to Find Out<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Even if a large trial goes forward, several questions remain open:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Dosing:<\/b><span style=\"font-weight: 400;\"> Whether diabetes-level doses are needed, or whether lower doses would offer similar benefits with fewer side effects.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Treatment duration:<\/b><span style=\"font-weight: 400;\"> How many years of use would be needed to affect aging, and whether starting age matters.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Long-term outcomes:<\/b><span style=\"font-weight: 400;\"> Whether biomarker changes translate into fewer diseases, better function, or longer life.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Patient selection:<\/b><span style=\"font-weight: 400;\"> Whether benefits are limited to people with insulin resistance or other metabolic risk factors.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Possible risks:<\/b><span style=\"font-weight: 400;\"> How long-term use affects muscle, exercise capacity, and B12 status in otherwise healthy older adults.<\/span><\/li>\n<\/ul>\n<h2><span style=\"font-weight: 400;\">Conclusion<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Metformin for longevity sits where solid science meets early hype. The drug is a trusted, low-cost diabetes treatment that acts on several pathways tied to aging, and that biology is genuinely interesting. What is missing is direct proof in the people most curious about it: adults whose blood sugar is normal.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Until a trial like TAME is funded, completed, and published, the fairest summary is that metformin is a candidate under study rather than a longevity treatment. If the topic matters to you, bring it to a clinician who can check your metabolic health and help you weigh real risks against uncertain rewards.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">Frequently Asked Questions<\/span><\/h2>\n<h3><span style=\"font-weight: 400;\">Does metformin really slow aging?<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Nobody knows yet, and it helps to be clear about what would settle it. Proof would come from a large randomized trial showing that people on metformin develop age-related diseases later than people on placebo. Changes in gene activity, inflammation markers, or animal lifespan are useful clues, but they are not that proof. Until such a trial reports, &#8220;may slow aging&#8221; is the most accurate phrasing.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Is metformin approved for longevity?<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">No, and under current rules no drug can be. The FDA approves medicines to treat or prevent specific diseases or conditions, and aging is not recognized as one. That gap is a major reason TAME was designed around delaying several specific illnesses instead of aging itself. Any prescription written for longevity today would be off-label and based on a clinician&#8217;s judgment, not on an approved indication.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">What is the TAME trial?<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">TAME, short for Targeting Aging with Metformin, is a planned placebo-controlled study meant to test whether a single inexpensive drug can delay several diseases of aging at once in older adults without diabetes. Beyond metformin, it is meant to serve as a template that future aging drugs could follow to reach regulators. Its proposed design and current status are described in detail in the TAME section of this article.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Has the TAME trial published results?<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">No results exist. Once the trial launches, the planned follow-up of about six years plus time for analysis means findings would arrive years later. To check progress yourself, look at AFAR&#8217;s official TAME page, search ClinicalTrials.gov for an active listing, and watch for results in peer-reviewed journals. Be wary of social media or supplement sites that describe TAME outcomes, since none have been reported.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Can healthy people take metformin?<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Only with a prescription from a licensed clinician who has reviewed their health. Buying metformin online without a prescription is risky, because unlicensed websites may sell products that are counterfeit, contaminated, or the wrong strength. The FDA&#8217;s BeSafeRx program explains how to recognize a legitimate online pharmacy. A clinician can also check blood sugar and kidney function first, which matters for both safety and whether there is any reason to use it.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Does metformin increase human lifespan?<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">That specific question has never been tested in people without diabetes, and even TAME would not answer it alone. Its main outcome combines several diseases and death into one measure, so a positive result would show delayed illness rather than a precise gain in years lived. Answering the lifespan question directly would need an even larger and longer trial, which is one reason the question may stay open for some time.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">What are the long-term risks of metformin?<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Most long-term safety knowledge comes from decades of use in people with diabetes, where the drug is generally well tolerated with monitoring. Ongoing care typically means a kidney function test at least once a year, periodic vitamin B12 checks, and a review before surgery or contrast scans. What is far less known is the effect of many years of use in metabolically healthy adults, because large, lengthy studies in that group have not been done.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Should people without diabetes take metformin for anti-aging?<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">The evidence does not support it today. A more productive step is asking your clinician for an A1C or fasting glucose test, since finding prediabetes would change the conversation and the options. If you are interested in contributing to aging research, ClinicalTrials.gov lists studies that are recruiting. Your clinician can also point you to the prevention steps best supported for your own risk profile.<\/span><\/p>\n<p><span style=\"font-weight: 400;\"><strong>Medical disclaimer<\/strong>: This review summarizes published research and the TAME trial&#8217;s status as of November 2026, and findings may change as new studies appear. It is not a recommendation to take metformin. Metformin is not FDA-approved for aging or longevity, so talk with a licensed prescriber about your own health before considering it. NuLifeSpan Rx is a discount program for prescriptions and is not insurance.<\/span><\/p>\n<p><script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@type\": \"FAQPage\",\n  \"mainEntity\": [\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Does metformin really slow aging?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"It is not yet proven that metformin slows aging in humans. Animal studies and changes in biological markers suggest possible benefits, but large randomized clinical trials are needed to demonstrate whether metformin delays age-related diseases.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Is metformin approved for longevity?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"No. The FDA has not approved metformin for longevity or anti-aging. Metformin is approved for treating type 2 diabetes, and prescribing it specifically for longevity would be considered off-label use.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"What is the TAME trial?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"TAME stands for Targeting Aging with Metformin. It is a proposed randomized, placebo-controlled clinical trial designed to investigate whether metformin can delay multiple age-related diseases in older adults without diabetes.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Has the TAME trial published results?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"No TAME trial results have been reported. The proposed study would require several years of follow-up after enrollment begins. Current information can be checked through the American Federation for Aging Research (AFAR), ClinicalTrials.gov, and peer-reviewed publications.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Can healthy people take metformin?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Metformin is a prescription medication and should only be taken under the supervision of a licensed healthcare professional. A clinician should review medical history, blood sugar, kidney function, and potential risks before considering treatment.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Does metformin increase human lifespan?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"There is no conclusive evidence that metformin increases lifespan in people without diabetes. Observational studies involving people with diabetes cannot establish a longevity benefit for healthy adults. The proposed TAME trial focuses on delaying age-related diseases rather than directly measuring lifespan extension.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"What are the long-term risks of metformin?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Potential risks include gastrointestinal side effects, vitamin B12 deficiency, and rare but serious lactic acidosis, particularly in people with certain medical conditions. Long-term use requires appropriate kidney function monitoring and periodic assessment of vitamin B12 levels.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Should people without diabetes take metformin for anti-aging?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Current evidence does not support routinely taking metformin for anti-aging in people without diabetes. Individuals interested in healthy aging should consult a clinician about evidence-based prevention, metabolic health screening, and appropriate clinical research opportunities.\"\n      }\n    }\n  ]\n}\n<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Metformin for longevity is a popular idea, but it is not a proven one. Metformin is a decades-old, low-cost type 2 diabetes drug that affects several biological pathways linked to aging, and some studies of people with diabetes suggest metformin users live longer than expected. However, no completed randomized trial has shown that metformin slows [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2274,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[5],"tags":[],"ppma_author":[17],"class_list":["post-2271","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharmacy-discounts","et-has-post-format-content","et_post_format-et-post-format-standard"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Metformin for Longevity: What Research and TAME Show<\/title>\n<meta name=\"description\" content=\"Metformin for longevity is still unproven. A clear look at animal, observational, and trial evidence, the real status of the TAME trial, and the risks to weigh.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nulifespanrx.com\/blog\/metformin-for-longevity-tame-trial\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Metformin for Longevity: What Research and TAME Show\" \/>\n<meta property=\"og:description\" content=\"Metformin for longevity is still unproven. A clear look at animal, observational, and trial evidence, the real status of the TAME trial, and the risks to weigh.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nulifespanrx.com\/blog\/metformin-for-longevity-tame-trial\/\" \/>\n<meta property=\"og:site_name\" content=\"NuLifeSpan Rx Savings Guide\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/nulifespanrx\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-13T16:24:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nulifespanrx.com\/blog\/wp-content\/uploads\/2026\/11\/metformin-for-longevity-research-and-healthy-aging.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Dr. Ethan Vale\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Ethan Vale\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"18 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nulifespanrx.com\\\/blog\\\/metformin-for-longevity-tame-trial\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nulifespanrx.com\\\/blog\\\/metformin-for-longevity-tame-trial\\\/\"},\"author\":{\"name\":\"Dr. Ethan Vale\",\"@id\":\"https:\\\/\\\/nulifespanrx.com\\\/blog\\\/#\\\/schema\\\/person\\\/a5c12154e223e6f419401d6e39c06f5b\"},\"headline\":\"Metformin for Longevity: What the Research and the TAME Trial Actually Show\",\"datePublished\":\"2026-11-13T16:24:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nulifespanrx.com\\\/blog\\\/metformin-for-longevity-tame-trial\\\/\"},\"wordCount\":3661,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nulifespanrx.com\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nulifespanrx.com\\\/blog\\\/metformin-for-longevity-tame-trial\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nulifespanrx.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/metformin-for-longevity-research-and-healthy-aging.webp\",\"articleSection\":[\"Pharmacy Discounts\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nulifespanrx.com\\\/blog\\\/metformin-for-longevity-tame-trial\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nulifespanrx.com\\\/blog\\\/metformin-for-longevity-tame-trial\\\/\",\"url\":\"https:\\\/\\\/nulifespanrx.com\\\/blog\\\/metformin-for-longevity-tame-trial\\\/\",\"name\":\"Metformin for Longevity: What Research and TAME Show\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nulifespanrx.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nulifespanrx.com\\\/blog\\\/metformin-for-longevity-tame-trial\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nulifespanrx.com\\\/blog\\\/metformin-for-longevity-tame-trial\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nulifespanrx.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/metformin-for-longevity-research-and-healthy-aging.webp\",\"datePublished\":\"2026-11-13T16:24:46+00:00\",\"description\":\"Metformin for longevity is still unproven. A clear look at animal, observational, and trial evidence, the real status of the TAME trial, and the risks to weigh.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nulifespanrx.com\\\/blog\\\/metformin-for-longevity-tame-trial\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nulifespanrx.com\\\/blog\\\/metformin-for-longevity-tame-trial\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/nulifespanrx.com\\\/blog\\\/metformin-for-longevity-tame-trial\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nulifespanrx.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/metformin-for-longevity-research-and-healthy-aging.webp\",\"contentUrl\":\"https:\\\/\\\/nulifespanrx.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/metformin-for-longevity-research-and-healthy-aging.webp\",\"width\":800,\"height\":500,\"caption\":\"Metformin and Healthy Aging Research\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nulifespanrx.com\\\/blog\\\/metformin-for-longevity-tame-trial\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nulifespanrx.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Metformin for Longevity: What the Research and the TAME Trial Actually Show\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nulifespanrx.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/nulifespanrx.com\\\/blog\\\/\",\"name\":\"NuLifeSpan Rx Savings Guide\",\"description\":\"Save on medications\",\"publisher\":{\"@id\":\"https:\\\/\\\/nulifespanrx.com\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nulifespanrx.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nulifespanrx.com\\\/blog\\\/#organization\",\"name\":\"NuLifeSpan Rx Savings Guide\",\"url\":\"https:\\\/\\\/nulifespanrx.com\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/nulifespanrx.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nulifespanrx.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Horizontal-on-light-bg.png\",\"contentUrl\":\"https:\\\/\\\/nulifespanrx.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Horizontal-on-light-bg.png\",\"width\":593,\"height\":98,\"caption\":\"NuLifeSpan Rx Savings Guide\"},\"image\":{\"@id\":\"https:\\\/\\\/nulifespanrx.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/nulifespanrx\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nulifespanrx.com\\\/blog\\\/#\\\/schema\\\/person\\\/a5c12154e223e6f419401d6e39c06f5b\",\"name\":\"Dr. Ethan Vale\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/?s=96&d=mm&r=g23494c9101089ad44ae88ce9d2f56aac\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/?s=96&d=mm&r=g\",\"caption\":\"Dr. Ethan Vale\"},\"description\":\"Dr. Ethan Vale is a wellness researcher and performance-focused health writer with over a decade of experience exploring longevity, nutrition, recovery, and evidence-based supplementation.\",\"url\":\"https:\\\/\\\/nulifespanrx.com\\\/blog\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Metformin for Longevity: What Research and TAME Show","description":"Metformin for longevity is still unproven. A clear look at animal, observational, and trial evidence, the real status of the TAME trial, and the risks to weigh.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nulifespanrx.com\/blog\/metformin-for-longevity-tame-trial\/","og_locale":"en_US","og_type":"article","og_title":"Metformin for Longevity: What Research and TAME Show","og_description":"Metformin for longevity is still unproven. A clear look at animal, observational, and trial evidence, the real status of the TAME trial, and the risks to weigh.","og_url":"https:\/\/nulifespanrx.com\/blog\/metformin-for-longevity-tame-trial\/","og_site_name":"NuLifeSpan Rx Savings Guide","article_publisher":"https:\/\/www.facebook.com\/nulifespanrx","article_published_time":"2026-11-13T16:24:46+00:00","og_image":[{"width":800,"height":500,"url":"https:\/\/nulifespanrx.com\/blog\/wp-content\/uploads\/2026\/11\/metformin-for-longevity-research-and-healthy-aging.webp","type":"image\/webp"}],"author":"Dr. Ethan Vale","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Ethan Vale","Est. reading time":"18 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nulifespanrx.com\/blog\/metformin-for-longevity-tame-trial\/#article","isPartOf":{"@id":"https:\/\/nulifespanrx.com\/blog\/metformin-for-longevity-tame-trial\/"},"author":{"name":"Dr. Ethan Vale","@id":"https:\/\/nulifespanrx.com\/blog\/#\/schema\/person\/a5c12154e223e6f419401d6e39c06f5b"},"headline":"Metformin for Longevity: What the Research and the TAME Trial Actually Show","datePublished":"2026-11-13T16:24:46+00:00","mainEntityOfPage":{"@id":"https:\/\/nulifespanrx.com\/blog\/metformin-for-longevity-tame-trial\/"},"wordCount":3661,"commentCount":0,"publisher":{"@id":"https:\/\/nulifespanrx.com\/blog\/#organization"},"image":{"@id":"https:\/\/nulifespanrx.com\/blog\/metformin-for-longevity-tame-trial\/#primaryimage"},"thumbnailUrl":"https:\/\/nulifespanrx.com\/blog\/wp-content\/uploads\/2026\/11\/metformin-for-longevity-research-and-healthy-aging.webp","articleSection":["Pharmacy Discounts"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nulifespanrx.com\/blog\/metformin-for-longevity-tame-trial\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nulifespanrx.com\/blog\/metformin-for-longevity-tame-trial\/","url":"https:\/\/nulifespanrx.com\/blog\/metformin-for-longevity-tame-trial\/","name":"Metformin for Longevity: What Research and TAME Show","isPartOf":{"@id":"https:\/\/nulifespanrx.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nulifespanrx.com\/blog\/metformin-for-longevity-tame-trial\/#primaryimage"},"image":{"@id":"https:\/\/nulifespanrx.com\/blog\/metformin-for-longevity-tame-trial\/#primaryimage"},"thumbnailUrl":"https:\/\/nulifespanrx.com\/blog\/wp-content\/uploads\/2026\/11\/metformin-for-longevity-research-and-healthy-aging.webp","datePublished":"2026-11-13T16:24:46+00:00","description":"Metformin for longevity is still unproven. A clear look at animal, observational, and trial evidence, the real status of the TAME trial, and the risks to weigh.","breadcrumb":{"@id":"https:\/\/nulifespanrx.com\/blog\/metformin-for-longevity-tame-trial\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nulifespanrx.com\/blog\/metformin-for-longevity-tame-trial\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/nulifespanrx.com\/blog\/metformin-for-longevity-tame-trial\/#primaryimage","url":"https:\/\/nulifespanrx.com\/blog\/wp-content\/uploads\/2026\/11\/metformin-for-longevity-research-and-healthy-aging.webp","contentUrl":"https:\/\/nulifespanrx.com\/blog\/wp-content\/uploads\/2026\/11\/metformin-for-longevity-research-and-healthy-aging.webp","width":800,"height":500,"caption":"Metformin and Healthy Aging Research"},{"@type":"BreadcrumbList","@id":"https:\/\/nulifespanrx.com\/blog\/metformin-for-longevity-tame-trial\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nulifespanrx.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Metformin for Longevity: What the Research and the TAME Trial Actually Show"}]},{"@type":"WebSite","@id":"https:\/\/nulifespanrx.com\/blog\/#website","url":"https:\/\/nulifespanrx.com\/blog\/","name":"NuLifeSpan Rx Savings Guide","description":"Save on medications","publisher":{"@id":"https:\/\/nulifespanrx.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nulifespanrx.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/nulifespanrx.com\/blog\/#organization","name":"NuLifeSpan Rx Savings Guide","url":"https:\/\/nulifespanrx.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/nulifespanrx.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/nulifespanrx.com\/blog\/wp-content\/uploads\/2026\/03\/Horizontal-on-light-bg.png","contentUrl":"https:\/\/nulifespanrx.com\/blog\/wp-content\/uploads\/2026\/03\/Horizontal-on-light-bg.png","width":593,"height":98,"caption":"NuLifeSpan Rx Savings Guide"},"image":{"@id":"https:\/\/nulifespanrx.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/nulifespanrx"]},{"@type":"Person","@id":"https:\/\/nulifespanrx.com\/blog\/#\/schema\/person\/a5c12154e223e6f419401d6e39c06f5b","name":"Dr. Ethan Vale","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g23494c9101089ad44ae88ce9d2f56aac","url":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","caption":"Dr. Ethan Vale"},"description":"Dr. Ethan Vale is a wellness researcher and performance-focused health writer with over a decade of experience exploring longevity, nutrition, recovery, and evidence-based supplementation.","url":"https:\/\/nulifespanrx.com\/blog\/author\/admin\/"}]}},"authors":[{"term_id":17,"user_id":1,"is_guest":0,"slug":"admin","display_name":"Dr. Ethan Vale","avatar_url":{"url":"https:\/\/nulifespanrx.com\/blog\/wp-content\/uploads\/2026\/05\/7e3414b5-1c05-4d53-81e7-ad66bbf11f5c.webp","url2x":"https:\/\/nulifespanrx.com\/blog\/wp-content\/uploads\/2026\/05\/7e3414b5-1c05-4d53-81e7-ad66bbf11f5c.webp"},"author_category":"1","first_name":"Dr. Ethan Vale","last_name":"","user_url":"","job_title":"","description":"Dr. Ethan Vale is a wellness researcher and performance-focused health writer with over a decade of experience exploring longevity, nutrition, recovery, and evidence-based supplementation."}],"_links":{"self":[{"href":"https:\/\/nulifespanrx.com\/blog\/wp-json\/wp\/v2\/posts\/2271","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nulifespanrx.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nulifespanrx.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nulifespanrx.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nulifespanrx.com\/blog\/wp-json\/wp\/v2\/comments?post=2271"}],"version-history":[{"count":2,"href":"https:\/\/nulifespanrx.com\/blog\/wp-json\/wp\/v2\/posts\/2271\/revisions"}],"predecessor-version":[{"id":2288,"href":"https:\/\/nulifespanrx.com\/blog\/wp-json\/wp\/v2\/posts\/2271\/revisions\/2288"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nulifespanrx.com\/blog\/wp-json\/wp\/v2\/media\/2274"}],"wp:attachment":[{"href":"https:\/\/nulifespanrx.com\/blog\/wp-json\/wp\/v2\/media?parent=2271"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nulifespanrx.com\/blog\/wp-json\/wp\/v2\/categories?post=2271"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nulifespanrx.com\/blog\/wp-json\/wp\/v2\/tags?post=2271"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/nulifespanrx.com\/blog\/wp-json\/wp\/v2\/ppma_author?post=2271"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}